Virbac Logo

Virbac

Develops animal health pharma, vaccines & diagnostics for vets, farmers & pet owners globally.

FR000 | PA

Overview

Corporate Details

ISIN(s):
FR0000031577
LEI:
969500QQ1X5XHG649644
Country:
France
Address:
1ERE AVENUE, 06510 CARROS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Virbac is an independent pharmaceutical company exclusively dedicated to animal health. Founded in 1968 by a veterinarian, the company develops, manufactures, and distributes a comprehensive range of products and services for veterinarians, farmers, and pet owners. Operating in over 100 countries, its portfolio offers innovative solutions covering the majority of animal species and diseases. Key product areas include pharmaceuticals, vaccines, parasite control, dental care, nutritional supplements, and diagnostic tools, all aimed at shaping the future of animal health.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-12 17:45
Earnings Release
VIRBAC: résultats semestriels 2025
French 1.2 MB
2025-09-12 17:45
Earnings Release
Virbac: 2025 Half-year results
English 1.1 MB
2025-09-12 17:30
Interim Report
Virbac : Rapport financier semestriel 2025
French 13.2 MB
2025-09-12 17:30
Interim Report
Virbac : Half-yearly financial report 2025
English 13.4 MB
2025-09-12 17:30
Report Publication Announcement
Virbac : Communiqué de mise à disposition du rapport financier semestriel au 30…
French 264.9 KB
2025-09-12 17:30
Report Publication Announcement
Virbac : Public release of the Half-Year Financial Report at 30 June 2025.
English 264.6 KB
2025-08-18 09:30
Remuneration Information
VIRBAC: Informations sur les conditions de rémunération de Paul Martingell
French 80.5 KB
2025-08-18 09:30
Remuneration Information
Virbac:: Paul Martingell's compensation terms
English 128.7 KB
2025-06-19 08:30
Board/Management Information
VIRBAC: Paul Martingell nommé directeur général du groupe Virbac au 1er septemb…
French 271.7 KB
2025-06-19 08:30
Board/Management Information
VIRBAC: Paul Martingell is appointed chief executive officer of Virbac, effecti…
English 279.3 KB
2025-06-10 09:59
Declaration of Voting Results & Voting Rights Announcements
Virbac : Declaration of the number of share and voting rights 05/2025
English 59.2 KB
2025-06-10 09:59
Declaration of Voting Results & Voting Rights Announcements
Virbac : Déclaration d'actions et de droits de vote 05/2025
French 36.6 KB
2025-05-26 10:05
Pre-Annual General Meeting Information
VIRBAC: Communiqué précisant les modalités de mise à disposition ou de consulta…
French 26.3 KB
2025-05-07 16:27
Declaration of Voting Results & Voting Rights Announcements
Virbac : Déclaration d'actions et de droits de vote 04/2025
French 36.6 KB
2025-04-28 19:00
Annual Report (ESEF)
Virbac : Rapport Annuel Virbac au 31 décembre 2024 (ESEF)
French 22.1 MB

Automate Your Workflow. Get a real-time feed of all Virbac filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Virbac via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-04-17 N/A Other Sell 370 135,790.00 EUR
2023-07-19 N/A Other Buy 950 245,100.00 EUR

Peer Companies

Company Country Ticker View
Corline Biomedical AB Logo
Develops heparin-based coatings for medical device biocompatibility and regenerative medicine.
Sweden CLBIO
Cosma Spolka Akcyjna Logo
Produces natural hemp supplements and pharmaceutical raw materials for retail & wholesale markets.
Poland COS
COSMO Pharmaceuticals N.V. Logo
Specialty pharma for gastroenterology/dermatology, offering colon treatments & manufacturing services.
Netherlands COPN
Crossject Logo
Develops needle-free auto-injectors for rapid drug delivery in medical emergencies.
France ALCJ
CTC BIO, INC. Logo
Develops pharmaceuticals and feed additives for human and animal health using fermentation tech.
South Korea 060590
Cuorips Inc. Logo
Develops iPS cell therapies, like a cardiomyocyte sheet for severe heart failure.
Japan 4894
curacle co., ltd. Logo
Developing drugs for intractable diseases like diabetes caused by vascular damage and aging.
South Korea 365270
Curevac Logo
Pioneering mRNA technology to create vaccines and therapies for infectious diseases, cancer, and more.
Germany CVAC
Curocell Inc. Logo
Biotech developing enhanced CAR-T therapies for cancer using its OVIS™ platform.
South Korea 372320
Cyfuse Biomedical K.K. Logo Japan 4892

Talk to a Data Expert

Have a question? We'll get back to you promptly.